90446-67-6

Basic information

• Product Name: Benzoyl chloride, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-
• CAS NO: 90446-67-6
• Molecular Formula: C13H19ClO2Si
• Molecular Weight: 270.831
• Mol File: 90446-67-6.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Benzoyl chloride, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoyl chloride, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-(90446-67-6)
• EPA Substance Registry System: Benzoyl chloride, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-(90446-67-6)

Safety Data

• Hazardous Substances Data: 90446-67-6(Hazardous Substances Data)

Upstream product

• 18162-48-6 tert-butyldimethylsilyl chloride 
• 99-96-7 4-hydroxy-benzoic acid 
• 83405-98-5 4-(tert-butyl-dimethylsilanyloxy)-benzoic acid 
• 78324-14-8 tert-butyldimethylsilyl 4-((tert-butyldimethylsilyl)oxy)benzoate 

Downstream Products

• 913985-93-0 (7-allyloxy-5,6-dimethoxy-1-methylene-3,4-dihydro-1H-isoquinolin-2-yl)-[4-(tert-butyl-dimethyl-silanyloxy)-phenyl]-methanone 
• 1449688-61-2 C₂₀H₁₃⁽³⁾H₃BrNO₆ 
• 1450590-56-3 C₁₈H₉⁽³⁾H₃BrNO₆ 
• 1449688-60-1 C₂₅H₂₈BrNO₆Si 
• 1567711-31-2 5-(4-(tert-butyldimethylsilyloxy)phenyl)-3-(4-(4-(trifluoromethyl)phenoxy)-phenyl)-1,2,4-oxadiazole 
• 1567711-33-4 5-(4-(tert-butyldimethylsilyloxy)phenyl)-3-(4-phenoxyphenyl)-1,2,4-oxadiazole 
• 1136832-74-0 5-(4-(tert-butyldimethylsilyloxy)phenyl)-3-(4-phenoxyphenyl)-1,2,4-oxadiazole 
• 885053-28-1 C₁₈H₂₃NO₃Si 
• 219603-31-3 (1R,2S)-(2-(4-hydroxybenzamido)-1-phenyl-1,3-propanediyl)bis(4-hydoxybenzoate) 
• 835873-07-9 N-(2-iodo-4-methylphenyl)-N-methyl-4-(trityloxy)benzamide 
• 835873-04-6 N-(2-iodophenyl)-N-methyl-4-(trityloxy)benzamide 
• 835873-05-7 benzoic acid 4-[N-(2-iodophenyl)methylcarbamoyl]phenyl ester 

Relevant articles and documents

Cell sugar transport channel inhibitor

The invention discloses a cell sugar transport channel inhibitor of which the structure is shown as a formula (I). The cell sugar transport channel inhibitor disclosed by the invention can target a cell sugar transport channel, and inhibit tumor cell prol

Discovery of a new class of non-β-lactam inhibitors of penicillin-binding proteins with gram-positive antibacterial activity

Infections caused by hard-to-treat methicillin-resistant Staphylococcus aureus (MRSA) are a serious global public-health concern, as MRSA has become broadly resistant to many classes of antibiotics. We disclose herein the discovery of a new class of non-β-lactam antibiotics, the oxadiazoles, which inhibit penicillin-binding protein 2a (PBP2a) of MRSA. The oxadiazoles show bactericidal activity against vancomycin-and linezolid-resistant MRSA and other Gram-positive bacterial strains, in vivo efficacy in a mouse model of infection, and have 100% oral bioavailability.

6-bromo-8-(4-[3H]methoxybenzamido)-4-oxo-4H-chromene-2- carboxylic acid: A powerful tool for studying orphan G protein-coupled receptor GPR35

The potent and selective GPR35 agonist 6-bromo-8-(4-methoxybenzamido)-4- oxo-4H-chromene-2-carboxylic acid (12) was obtained in tritium-labeled form, designated [3H]PSB-13253, with a specific activity of 36 Ci (1.33 TBq)/mmol. Radiolabeling was